|
|
|
| 31 December 1998, Volume 17, Number 26, Pages 3479-3491 |
| Table of contents Previous Abstract Next Article PDF |
 |
| Original article |
| Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs |
 |
| Michelle J Callaghan1, Amanda J Russell1, Erica Woollatt2, Grant R Sutherland2, Robert L Sutherland1 and Colin KW Watts1,a |
 |
1Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, NSW 2010, Australia
2Centre for Medical Genetics, Department of Cytogenetics and Molecular Genetics, Women's and Children's Hospital, Adelaide, SA 5006, Australia
|
 |
aAuthor for correspondence |
 |
| Abstract |
 | Use of the differential display technique to isolate progestin-regulated genes in T-47D human breast cancer cells led to identification of a novel gene, EDD. The cDNA sequence contains a 2799 amino acid open reading frame sharing 40% identity with the predicted 2894 amino acid product of the Drosophila melanogaster tumor suppressor gene hyperplastic discs, while the carboxy-terminal 889 amino acids show 96% identity to a rat 100 kDa HECT domain protein. EDD mRNA was progestin-induced in T-47D cells and was highly abundant in testes and expressed at moderately high levels in other tissues, suggesting a broad role for EDD. Anti-EDD antibodies immunoprecipitated an approximately 300 kDa protein from T-47D cell lysates. HECT family proteins function as E3 ubiquitin-protein ligases, targeting specific proteins for ubiquitin-mediated proteolysis. EDD is likely to function as an E3 as in vitro translated protein bound ubiquitin reversibly through a conserved HECT domain cysteine residue. EDD was localized by FISH to chromosome 8q22, a locus disrupted in a variety of cancers. Given the homology between EDD and the hyperplastic discs protein, which is required for control of imaginal disc growth in Drosophila, EDD potentially has a role in regulation of cell proliferation or differentiation. |
 |
| Keywords |
 | ubiquitination; tumor suppressor; progestin; breast cancer |
|
 |
 |
 |
| Received 29 May 1998; revised 26 June 1998; accepted 26 June 1998 |
 |
| 31 December 1998, Volume 17, Number 26, Pages 3479-3491 |
| Table of contents Previous Abstract Next Article PDF |
|
|